Literature DB >> 33252076

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study.

Qingze Zeng1, Kaicheng Li1, Xiao Luo1, Shuyue Wang1, Xiaopei Xu1, Zheyu Li2, Tianyi Zhang2, Xiaocao Liu1, Yanv Fu2, Xiaojun Xu1, Chao Wang1, Tao Wang1, Jiong Zhou2, Zhirong Liu2, Yanxing Chen2, Peiyu Huang1, Minming Zhang1.   

Abstract

BACKGROUND: Predicting the prognosis of mild cognitive impairment (MCI) has outstanding clinical value, and the hippocampal volume is a reliable imaging biomarker of AD diagnosis.
OBJECTIVE: We aimed to longitudinally assess hippocampal sub-regional difference (volume and asymmetry) among progressive MCI (pMCI), stable MCI (sMCI) patients, and normal elderly.
METHODS: We identified 29 pMCI, 52 sMCI, and 102 normal controls (NC) from the ADNI database. All participants underwent neuropsychological assessment and 3T MRI scans three times. The time interval between consecutive MRI sessions was about 1 year. Volumes of hippocampal subfield were measured by Freesurfer. Based on the analysis of variance, repeated measures analyses, and receiver operating characteristic curves, we compared cross-sectional and longitudinal alteration sub-regional volume and asymmetry index.
RESULTS: Compared to NC, both MCI groups showed significant atrophy in all subfields. At baseline, pMCI have a smaller volume than sMCI in the bilateral subiculum, molecular layer (ML), the molecular and granule cell layers of the dentate gyrus, cornu ammonis 4, and right tail. Furthermore, repeated measures analyses revealed that pMCI patients showed a faster volume loss than sMCI in bilateral subiculum and ML. After controlling for age, gender, and education, most results remained unchanged. However, none of the hippocampal sub-regional volumes performed better than the whole hippocampus in ROC analyses, and no asymmetric difference between pMCI and sMCI was found.
CONCLUSION: The faster volume loss in subiculum and ML suggest a higher risk of disease progression in MCI patients. The hippocampal asymmetry may have smaller value in predicting the MCI prognosis.

Entities:  

Keywords:  Alzheimer’s disease; hippocampal subfields; mild cognitive impairment; molecular layer; subiculum

Year:  2021        PMID: 33252076     DOI: 10.3233/JAD-200775

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.

Authors:  Sid E O'Bryant; Fan Zhang; Melissa Petersen; James R Hall; Leigh A Johnson; Kristine Yaffe; Meredith Braskie; Rocky Vig; Arthur W Toga; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease.

Authors:  David Silhan; Olga Pashkovska; Ales Bartos
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  Diagnostic Performance of Generative Adversarial Network-Based Deep Learning Methods for Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Changxing Qu; Yinxi Zou; Yingqiao Ma; Qin Chen; Jiawei Luo; Huiyong Fan; Zhiyun Jia; Qiyong Gong; Taolin Chen
Journal:  Front Aging Neurosci       Date:  2022-04-21       Impact factor: 5.750

4.  Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer's Disease.

Authors:  Alexandra Horvath; Patrick Quinlan; Carl Eckerström; N David Åberg; Anders Wallin; Johan Svensson
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

5.  Prediction of Subtle Cognitive Decline in Normal Aging: Added Value of Quantitative MRI and PET Imaging.

Authors:  Panteleimon Giannakopoulos; Marie-Louise Montandon; Cristelle Rodriguez; Sven Haller; Valentina Garibotto; François R Herrmann
Journal:  Front Aging Neurosci       Date:  2021-07-12       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.